1. Sahel, José-Alain, Marazova, Katia, Dalkara, Deniz. 2023. Gene augmentation in FAM161A ciliopathy: Toward functional vision rescue. In Molecular therapy : the journal of the American Society of Gene Therapy, 31, 2820-2822. doi:10.1016/j.ymthe.2023.09.005. https://pubmed.ncbi.nlm.nih.gov/37729904/
2. Arsenijevic, Yvan, Chang, Ning, Mercey, Olivier, Hamel, Virginie, Kostic, Corinne. 2024. Fine-tuning FAM161A gene augmentation therapy to restore retinal function. In EMBO molecular medicine, 16, 805-822. doi:10.1038/s44321-024-00053-x. https://pubmed.ncbi.nlm.nih.gov/38504136/
3. Matsevich, Chen, Gopalakrishnan, Prakadeeswari, Chang, Ning, Arsenijevic, Yvan, Banin, Eyal. 2023. Gene augmentation therapy attenuates retinal degeneration in a knockout mouse model of Fam161a retinitis pigmentosa. In Molecular therapy : the journal of the American Society of Gene Therapy, 31, 2948-2961. doi:10.1016/j.ymthe.2023.08.011. https://pubmed.ncbi.nlm.nih.gov/37580905/
4. Sharon, Dror, Ben-Yosef, Tamar, Goldenberg-Cohen, Nitza, Banin, Eyal, Perlman, Ido. 2019. A nationwide genetic analysis of inherited retinal diseases in Israel as assessed by the Israeli inherited retinal disease consortium (IIRDC). In Human mutation, 41, 140-149. doi:10.1002/humu.23903. https://pubmed.ncbi.nlm.nih.gov/31456290/
5. Karlstetter, Marcus, Sorusch, Nasrin, Caramoy, Albert, Wolfrum, Uwe, Langmann, Thomas. 2014. Disruption of the retinitis pigmentosa 28 gene Fam161a in mice affects photoreceptor ciliary structure and leads to progressive retinal degeneration. In Human molecular genetics, 23, 5197-210. doi:10.1093/hmg/ddu242. https://pubmed.ncbi.nlm.nih.gov/24833722/
智鼠故事 
